- Report
- September 2026
- 197 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- September 2026
- 199 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- November 2026
- 177 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 372 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- January 2026
- 185 Pages
Global
From €4240EUR$4,500USD£3,530GBP
- Report
- November 2025
- 185 Pages
Global
From €4240EUR$4,500USD£3,530GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2826EUR$3,000USD£2,353GBP
- Report
- February 2026
- 200 Pages
Global
From €7528EUR$7,990USD£6,268GBP
- Report
- May 2026
- 100 Pages
Global
From €2543EUR$2,699USD£2,117GBP
- Report
- April 2026
- 137 Pages
Global
From €3768EUR$3,999USD£3,137GBP
- Report
- August 2026
- 160 Pages
Global
From €3128EUR$3,320USD£2,604GBP
€3910EUR$4,150USD£3,255GBP
- Report
- September 2026
- 187 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- September 2026
- 194 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- January 2026
- 240 Pages
Global
From €3297EUR$3,500USD£2,745GBP
- Report
- May 2026
- 200 Pages
Global
From €2628EUR$2,789USD£2,188GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more